Janssen Sciences Ireland

Janssen Sciences Ireland, a subsidiary of Johnson & Johnson (operating under J&J Innovative Medicine), is a leading biopharmaceutical company based in Ringaskiddy, County Cork, Ireland. Established in 2005, the company operates a state-of-the-art manufacturing and R&D facility that serves as a strategic hub in J&J's global supply chain for biologics and small molecules. The site specializes in the production of advanced therapies for oncology, immunology, and infectious diseases, including blockbuster monoclonal antibodies such as Darzalex, Stelara, Tremfya, and Simponi. Additionally, Janssen Sciences Ireland has been a key developer of the HIV-1 treatment rilpivirine (Edurant), which is also utilized in long-acting combination therapies like Cabenuva. The facility is recognized globally for its manufacturing excellence, having been designated as an 'Industry 4.0 Lighthouse' by the World Economic Forum.